Bulletin of Experimental Biology and Medicine

, Volume 140, Issue 2, pp 228–230 | Cite as

Vascular Endothelium Growth Factor in the Sera of Patients with Adrenal Tumors

  • T. A. Britvin
  • I. A. Kazantseva
  • A. P. Kalinin
  • N. E. Kushlinskii


Serum levels of vascular endothelium growth factor were measured in 43 patients with adrenal tumors and 25 healthy subjects. The mean blood levels of the factor in patients with adrenal tumors significantly surpassed the control. No correlations between the level of vascular endothelium growth factor, patient's age and sex were detected. The levels of this factor were maximum in patients with adrenocortical cancer, but its mean level differed negligibly from that in other morphological variants of tumors. The level of vascular endothelium growth factor tended to increase with increasing the stage of adrenocortical cancer. A direct correlation was revealed between the level of vascular endothelium growth factor and tumor size in adrenocortical cancer and aldosterone-producing adenoma. Presumably, vascular endothelium growth factor is involved into mechanisms of growth, invasion, and metastatic growth of adrenocortical cancer.

Key Words

angiogenesis vascular endothelium growth factor adrenal tumors 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    A. F. Karamysheva, Carcinogenesis [in Russian], Moscow (2000), pp. 298–309.Google Scholar
  2. 2.
    G. P. Bernini, A. Moretti, A. G. Bonadio, et al., J. Clin. Endocrinol. Metab., 87, No.11, 4961–4965 (2002).CrossRefPubMedGoogle Scholar
  3. 3.
    F. De Vita, M. Orditura, E. Lieto, et al., Cancer, 100, No.2, 270–278 (2004).CrossRefPubMedGoogle Scholar
  4. 4.
    F. Fraipont, M. El Atifi, C. Gicquel, et al., J. Clin. Endocrinol. Metab., 85, No.12, 4734–4741 (2000).CrossRefPubMedGoogle Scholar
  5. 5.
    L. Li, L. Wang, W. Zhang, et al., Anticancer Res., 24, No.3b, 1973–1979 (2004).PubMedGoogle Scholar
  6. 6.
    R. T. Poon, J. W. Ho, C. S. Tong, et al., Br. J. Surg., 91, No.10, 1354–1360 (2004).CrossRefPubMedGoogle Scholar
  7. 7.
    K. Salmenkivi, P. Heikkila, J. Liu, et al. APMIS, 111, No.4, 458–464 (2003).CrossRefGoogle Scholar
  8. 8.
    Y. Shimanuki, K. Takahashi, R. Cui, et al., Lungs, 183, No.1, 29–42 (2005).CrossRefGoogle Scholar
  9. 9.
    H. E. Turner, A. L. Harris, S. Melmed, and J. A. H. Wass, Endocr. Rev., 24, No.5, 600–632 (2003).CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2005

Authors and Affiliations

  • T. A. Britvin
    • 1
  • I. A. Kazantseva
    • 1
  • A. P. Kalinin
    • 1
  • N. E. Kushlinskii
    • 2
  1. 1.M. F. Vladimirskii Moscow Regional Research and Clinical InstituteMoscowRussia
  2. 2.N. N. Blokhin Russian Oncological Research CenterRussian Academy of Medical SciencesMoscowRussia

Personalised recommendations